Drug Profile
Tridegin
Latest Information Update: 15 Aug 2002
Price :
$50
*
At a glance
- Originator Biopharm (UK)
- Class Antithrombotics; Peptides
- Mechanism of Action Factor XIII inhibitors; Transglutaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis